Stay updated on SRM003 Efficacy in Arteriovenous Graft Hemodialysis Access Clinical Trial

Sign up to get notified when there's something new on the SRM003 Efficacy in Arteriovenous Graft Hemodialysis Access Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SRM003 Efficacy in Arteriovenous Graft Hemodialysis Access Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:15:28.000Z thumbnail image
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update or modification in the efficacy evaluation of SRM003 treatment in extending the duration of primary patency after arteriovenous graft surgery for subjects with end-stage renal disease.
    Difference
    0.1%
    Check dated 2024-06-06T14:17:16.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying age, gender, health conditions, and other requirements. Previously, this section only indicated that no information was provided.
    Difference
    18%
    Check dated 2024-05-22T20:54:10.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:36:02.000Z thumbnail image

Stay in the know with updates to SRM003 Efficacy in Arteriovenous Graft Hemodialysis Access Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SRM003 Efficacy in Arteriovenous Graft Hemodialysis Access Clinical Trial page.